Where does Moraine Corporation rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Moraine Corporation ranks #10,690 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Moraine Corporation hold?

Moraine Corporation holds 29 US utility patents granted between 2016 and 2025, spanning 28 technology areas.

What is Moraine Corporation's Innovation Score?

Moraine Corporation has an Innovation Score of 40.8 out of 100 (top 35% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Moraine Corporation focus on?

Moraine Corporation's top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 14 patents, ranking #1,384 of 6,058 assignees active in that subclass. Grants appear in 28 CPC subclasses total.

Is Moraine Corporation's patent grant rate increasing or decreasing?

Moraine Corporation's recent grant velocity is +45% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Moraine Corporation's patents?

Moraine Corporation's patents average 9.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Moraine Corporation patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Moraine Corporation

USPTO PatentsView assignee record - 29 granted patents across 28 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Moraine ranks #10,690 of 49,997 tracked US assignees by granted-patent volume, with 29 patents across 28 technology areas.

#10,690
of 49,997 US assignees by volume: Top 35%
by Innovation Score (40.8/100): 9.8
avg claims per patent: +45%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R10690 · Foreign Corporation #10,690 · 29 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-PAR · TYPE-FRNCORP · VEL-UP · BOOK-FULL

GRANTS-SMALL 29 grants
UPPER-Q #10,690/49,997
PHOTO-FINISH MedTech
CPC-FOCUS A61P · 28 areas
INNOV-PAR 40.8/100
CLAIMS-PAR 9.8 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-UP +45% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: MedTech S.A. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Moraine’s 40.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.7 pts (29%) Velocity 4.4 pts (11%) Breadth 18.7 pts (46%) Claim depth 5.9 pts (14%)

Qualcomm Incorporated · highest

85
Jiangsu Advanced… · near

41
Lexisnexis Risk… · near

41
Moraine · this assignee

41
Stetrix · near

41
Knox Associates · near

41
3D Lighting… · lowest

7

What this shows Moraine's Innovation Score is 40.8/100 (top 35% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Moraine?

Each dot is one of Moraine’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Moraine’s own 9.8 claims/patent is at or below the 17.6 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Moraine vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Moraine's grants concentrate

Moraine Corporation is a focused PatentsView assignee: 28 CPC subclasses with 48.3% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2019 (4 grants) versus a trough of 1 in 2017. By volume, Moraine sits between MedTech S.A. and Myriad Women's Health, Inc..

Moraine's three-year grant acceleration

Moraine Corporation shows 8 grants in 2022–2024 against only 12 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Medtech

29
Micell

29
Mississippi Lime

29
Moderna Therapeut…

29
Moshun

29
Movellus Circuits

29
Myriad Genetics

29
Myriad Women's He…

29
Moraine ◀

29

What this shows Moraine holds 29 patents at rank #10,691, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Moraine

By rank, the assignees closest to #10,691 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Moraine's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Moraine, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Moraine ranks #1,384 of 6,058 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (41 here).

Stetrix, Inc. 41 Lexisnexis Risk Solutions FL Inc. 41 Jiangsu Advanced Memory Technology Co., Ltd. 41 Knox Associates, Inc. 41

Moraine's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

41 Top 35% higher than 65% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Moraine Corporation patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	3	10.3%
2017	1	3.4%
2018	3	10.3%
2019	4	13.8%
2020	4	13.8%
2021	4	13.8%
2022	2	6.9%
2023	4	13.8%
2024	2	6.9%
2025partial year	2	6.9%

Which technologies does Moraine Corporation patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 14

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 14

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 5

H04L - Transmission OF Digital Information, e.g. Telegraphic Communication 4

Y02A - Technologies FOR Adaptation TO Climate Change 4

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 3

C07K - Peptides 3

G06Q - Information AND Communication Technology [ICT] Specially Adapted FOR Administrative, Commercial, Financial, Managerial OR Supervisory PURPOSES; Systems OR Methods Specially Adapted FOR Administrative, Commercial, Financial, Managerial OR Supervisory Purposes, NOT Otherwise Provided FOR 3

B65D - Containers FOR Storage OR Transport OF Articles OR Materials, e.g. Bags, Barrels, Bottles, Boxes, Cans, Cartons, Crates, Drums, Jars, Tanks, Hoppers, Forwarding CONTAINERS; Accessories, Closures, OR Fittings THEREFOR; Packaging ELEMENTS; Packages 3

B29L - Indexing Scheme Associated With Subclass B29c, Relating TO Particular Articles 2

B29C - Shaping OR Joining OF PLASTICS; Shaping OF Material IN A Plastic State, NOT Otherwise Provided FOR; After-treatment OF THE Shaped Products, e.g. Repairing 2

B29K - Indexing Scheme Associated With Subclasses B29b, B29c OR B29d, Relating TO Moulding Materials OR TO Materials FOR ; Moulds, ; Reinforcements, Fillers OR Preformed Parts, e.g. Inserts 2

C08J - WORKING-UP; General Processes OF COMPOUNDING; After-treatment NOT Covered BY Subclasses C08b, C08c, C08f, C08g or C08h 2

B32B - Layered Products, i.e. Products Built-up OF Strata OF Flat OR Non-flat, e.g. Cellular OR Honeycomb, Form 2

C08L - Compositions OF Macromolecular Compounds 2

Top 15 of 28 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Moraine Corporation's patent record in context - here's where to go next.

Moraine Corporation's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 48.3% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #10,690 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Moraine Corporation against MedTech S.A., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 40.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.